Weidong Leng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Weidong Leng has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Shanshan Qin
Department of Stomatology, Hubei Provincial Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, Taihe Hospital, Hubei University of Medicine, Shiyan, China
13 shared publications Lingyun Xia
Department of Stomatology, Hubei Provincial Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, Taihe Hospital, Hubei University of Medicine, Shiyan, China
12 shared publicationsPan Huang
Hubei Key Laboratory of Embryonic Stem Cell Research, School of Basic Medical Sciences, Hubei University of Medicine, Shiyan, China
8 shared publications- Dandan Li
Department of Stomatology, Hubei Provincial Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, Taihe Hospital, Hubei University of Medicine, Shiyan, China
6 shared publications Qiwei Guo
Department of Stomatology, Taihe Hospital, School of Basic Medical Sciences, Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei University of Medicine, Shiyan, China
6 shared publicationsDandan Li
Department of Stomatology Hubei Provincial Clinical Research Center For Umbilical Cord Blood Hematopoietic Stem Cells Taihe Hospital Hubei University of Medicine Shiyan Hubei China
5 shared publications
Latest Publications
- Open Access
- 5 November 2026
- Published by Wiley in Advanced Science
Epigenetic Activation of ANGPTL4 Drives EBV‐Negative Gastric Cancer via Neutrophil Recruitment and NET Release via Stabilizing ANXA5
EBV‐positive (EBVaGC) and EBV‐negative (EBVnGC) gastric cancers exhibit distinct clinical outcomes, prognostic features, and immune infiltration landscapes; however, the molecular mechanisms driving these subtype differences, as well as the subtype‐specific epigenetic regulation and biological functions of ANGPTL4 within the immune microenvironment, remain unclear. Here, through integrated analysis of multi‐omics data, we discovered that EBV infection induces marked hypermethylation at the ANGPTL4 promoter, leading to transcriptional silencing of ANGPTL4 in EBVaGC. Conversely, hypomethylation‐mediated ANGPTL4 overexpression is clinically associated with poor prognosis and distant metastasis in EBVnGC. Mechanistically, the C‐terminal secreted form (cANGPTL4) promotes GC progression by enhancing proliferation, epithelial‐mesenchymal transition (EMT), and neutrophil recruitment. Clinically, ANGPTL4 expression is positively correlated with neutrophil infiltration and neutrophil extracellular traps (NETs) levels in GC. Spatial transcriptomics and immunohistochemistry (IHC) analyses confirmed the spatial colocalization of ANGPTL4 with tumor‐infiltrating neutrophils. cANGPTL4 mediates tumor‐associated neutrophil (TAN) recruitment via the NF‐κB/CXCL8 axis and directly binds and stabilizes neutrophil‐derived ANXA5 to facilitate NET release, thereby driving GC progression. In conclusion, ANGPTL4 represents a potential intervention target for EBVnGC. Targeting ANGPTL4 may exert dual anti‐tumor effects by directly suppressing GC proliferation, EMT, and metastasis, and by remodeling the immunosuppressive microenvironment via attenuating TANs infiltration and NET release.
- 5 November 2026
- Published by Wiley in Advanced Science
Open AccessEpigenetic Activation of ANGPTL4 Drives EBV‐Negative Gastric Cancer via Neutrophil Recruitment and NET Release via Stabilizing ANXA5
EBV‐positive (EBVaGC) and EBV‐negative (EBVnGC) gastric cancers exhibit distinct clinical outcomes, prognostic features, and immune infiltration landscapes; however, the molecular mechanisms driving these subtype differences, as well as the subtype‐specific epigenetic regulation and biological functions of ANGPTL4 within the immune microenvironment, remain unclear. Here, through integrated analysis of multi‐omics data, we discovered that EBV infection induces marked hypermethylation at the ANGPTL4 promoter, leading to transcriptional silencing of ANGPTL4 in EBVaGC. Conversely, hypomethylation‐mediated ANGPTL4 overexpression is clinically associated with poor prognosis and distant metastasis in EBVnGC. Mechanistically, the C‐terminal secreted form (cANGPTL4) promotes GC progression by enhancing proliferation, epithelial‐mesenchymal transition (EMT), and neutrophil recruitment. Clinically, ANGPTL4 expression is positively correlated with neutrophil infiltration and neutrophil extracellular traps (NETs) levels in GC. Spatial transcriptomics and immunohistochemistry (IHC) analyses confirmed the spatial colocalization of ANGPTL4 with tumor‐infiltrating neutrophils. cANGPTL4 mediates tumor‐associated neutrophil (TAN) recruitment via the NF‐κB/CXCL8 axis and directly binds and stabilizes neutrophil‐derived ANXA5 to facilitate NET release, thereby driving GC progression. In conclusion, ANGPTL4 represents a potential intervention target for EBVnGC. Targeting ANGPTL4 may exert dual anti‐tumor effects by directly suppressing GC proliferation, EMT, and metastasis, and by remodeling the immunosuppressive microenvironment via attenuating TANs infiltration and NET release.
- Open Access
- 3 June 2026
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
Vascular SMC-like CAF-derived THBS1 drives tumor-associated neutrophil recruitment to orchestrate an immunosuppressive microenvironment in gastric cancer
The immunosuppressive tumor microenvironment (TME) remains a primary barrier to effective immunotherapy. Tumor-associated neutrophils (TANs) are key contributors to this immunosuppressive landscape; however, the mechanisms governing their recruitment and infiltration into tumor tissues remain poorly understood. In this study, we unravel a pro-tumorigenic role of thrombospondin-1 (THBS1) in gastric cancer (GC) mediated by TAN recruitment. By integrating single-cell RNA sequencing with immunohistochemical analyses, we demonstrated that THBS1 is predominantly expressed in vascular smooth muscle cell (VSMC)-like cancer-associated fibroblast (CAF), with lower expression observed in malignant epithelial cells. Notably, THBS1-expressing CAFs are significantly expanded in GC tissues. Accordingly, THBS1 is upregulated in GC, and its overexpression is clinically associated with malignant progression and poor prognosis. Genetic depletion of THBS1 in CAFs markedly suppressed GC progression both in vitro and in vivo. Furthermore, deconvolution analysis, patient-derived xenograft (PDX) models, and multiplex immunofluorescence (mIHC) revealed a pronounced spatial co-localization between THBS1-positive CAFs and TANs within GC tissues. TAN infiltration was significantly elevated in GC and positively correlated with THBS1 expression levels and adverse survival outcomes. Critically, neutralizing THBS1 with monoclonal antibodies or specifically knocking down THBS1 in CAFs dramatically reduced TAN infiltration in both PDX and nude mouse xenograft models. Mechanistically, THBS1 knockdown in CAFs impaired the autocrine production and secretion of key neutrophil-attracting chemokines, including CXCL1, CXCL5, and CXCL6. In summary, our findings underscore the significance of SMC-like CAF-derived THBS1 as a critical molecular mediator in the dynamic interplay between CAFs and TANs, ultimately driving GC progression.
- 3 June 2026
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
Open AccessVascular SMC-like CAF-derived THBS1 drives tumor-associated neutrophil recruitment to orchestrate an immunosuppressive microenvironment in gastric cancer
The immunosuppressive tumor microenvironment (TME) remains a primary barrier to effective immunotherapy. Tumor-associated neutrophils (TANs) are key contributors to this immunosuppressive landscape; however, the mechanisms governing their recruitment and infiltration into tumor tissues remain poorly understood. In this study, we unravel a pro-tumorigenic role of thrombospondin-1 (THBS1) in gastric cancer (GC) mediated by TAN recruitment. By integrating single-cell RNA sequencing with immunohistochemical analyses, we demonstrated that THBS1 is predominantly expressed in vascular smooth muscle cell (VSMC)-like cancer-associated fibroblast (CAF), with lower expression observed in malignant epithelial cells. Notably, THBS1-expressing CAFs are significantly expanded in GC tissues. Accordingly, THBS1 is upregulated in GC, and its overexpression is clinically associated with malignant progression and poor prognosis. Genetic depletion of THBS1 in CAFs markedly suppressed GC progression both in vitro and in vivo. Furthermore, deconvolution analysis, patient-derived xenograft (PDX) models, and multiplex immunofluorescence (mIHC) revealed a pronounced spatial co-localization between THBS1-positive CAFs and TANs within GC tissues. TAN infiltration was significantly elevated in GC and positively correlated with THBS1 expression levels and adverse survival outcomes. Critically, neutralizing THBS1 with monoclonal antibodies or specifically knocking down THBS1 in CAFs dramatically reduced TAN infiltration in both PDX and nude mouse xenograft models. Mechanistically, THBS1 knockdown in CAFs impaired the autocrine production and secretion of key neutrophil-attracting chemokines, including CXCL1, CXCL5, and CXCL6. In summary, our findings underscore the significance of SMC-like CAF-derived THBS1 as a critical molecular mediator in the dynamic interplay between CAFs and TANs, ultimately driving GC progression.
- Open Access
- 3 November 2025
- Published by Springer Nature in Experimental & Molecular Medicine
- Vol. 57 (11) , 2440-2457
EHBMT, a method for visualizing tumor evolution, identifies a surge in gastric cancer with hybrid epithelial–mesenchymal phenotypes due to an inflammatory microenvironment
A method for analyzing tumor evolution based on bulk RNA-sequencing data has not been reported yet. The epithelial–mesenchymal transition (EMT) is an evolutionarily conserved cellular program with high heterogeneity and plasticity. In this study, we proposed an EMT heterogeneity-based molecular typing (EHBMT) method to visualize cancer evolution and guide personalized medicine. Multiplex immunohistochemical assay and single-cell analysis were performed to confirm the feasibility of this method. EHBMT divided gastric (cancer) tissues into an epithelial phenotype cluster (EPC), hybrid epithelial–mesenchymal phenotype cluster (HPC) and mesenchymal phenotype cluster (MPC). Patients with gastric cancer with different EHBMT subtypes possessed distinct clinical features, molecular characteristics and prognostic outcomes. Furthermore, the proliferation ability of EPC, HPC and MPC subtypes decreases sequentially. Gene Ontology/Kyoto Encyclopedia of Genes and Genomes analysis showed that HPC subtypes are associated with inflammation and immune activation. More importantly, EHBMT discovered a sharp increase in the proportion of the HPC subtype during gastric cancer evolution. Traceability analysis indicated that the surge in HPC in gastric cancer was due to the transition from approximately 70–80% of normal EPC cases to cancerous HPC/MPC cases. In addition, the inflammatory factor IL-1β, highly expressed epithelial cells in the HPC subtype, should be a key driver for the decrease of epithelial cells by inducing EMT signaling. In conclusion, EHBMT is a novel method for visualizing cancer evolution using bulk transcriptomics. Gastric carcinogenesis is accompanied by a sharp increase in the proportion of HPC due to the abnormal EMT signaling pathway driven by an inflammatory microenvironment.
- 3 November 2025
- Published by Springer Nature in Experimental & Molecular Medicine
- Vol. 57 (11) , 2440-2457
Open AccessEHBMT, a method for visualizing tumor evolution, identifies a surge in gastric cancer with hybrid epithelial–mesenchymal phenotypes due to an inflammatory microenvironment
A method for analyzing tumor evolution based on bulk RNA-sequencing data has not been reported yet. The epithelial–mesenchymal transition (EMT) is an evolutionarily conserved cellular program with high heterogeneity and plasticity. In this study, we proposed an EMT heterogeneity-based molecular typing (EHBMT) method to visualize cancer evolution and guide personalized medicine. Multiplex immunohistochemical assay and single-cell analysis were performed to confirm the feasibility of this method. EHBMT divided gastric (cancer) tissues into an epithelial phenotype cluster (EPC), hybrid epithelial–mesenchymal phenotype cluster (HPC) and mesenchymal phenotype cluster (MPC). Patients with gastric cancer with different EHBMT subtypes possessed distinct clinical features, molecular characteristics and prognostic outcomes. Furthermore, the proliferation ability of EPC, HPC and MPC subtypes decreases sequentially. Gene Ontology/Kyoto Encyclopedia of Genes and Genomes analysis showed that HPC subtypes are associated with inflammation and immune activation. More importantly, EHBMT discovered a sharp increase in the proportion of the HPC subtype during gastric cancer evolution. Traceability analysis indicated that the surge in HPC in gastric cancer was due to the transition from approximately 70–80% of normal EPC cases to cancerous HPC/MPC cases. In addition, the inflammatory factor IL-1β, highly expressed epithelial cells in the HPC subtype, should be a key driver for the decrease of epithelial cells by inducing EMT signaling. In conclusion, EHBMT is a novel method for visualizing cancer evolution using bulk transcriptomics. Gastric carcinogenesis is accompanied by a sharp increase in the proportion of HPC due to the abnormal EMT signaling pathway driven by an inflammatory microenvironment.
- Open Access
- 6 October 2025
- Published by Springer Nature in Cell Death & Disease
- Vol. 16 (1) , 1-15
Hypermethylation-mediated HNF4A silencing by Helicobacter pylori infection drives gastric cancer by disrupting epithelial cell polarity and activating EMT signaling
Helicobacter pylori (Hp.) infection is one of the high-risk factors for gastric carcinogenesis (GC). However, the underlying mechanism remains largely unclear. In this study, we uncover an essential role of Hp. infection in mediating tumor suppressor gene silencing in gastric epithelial cells through promoter DNA hypermethylation. Hepatocyte nuclear factor HNF4A was downregulated in GC and predicted poor survival. The in vitro and in vivo assays together confirmed that HNF4A plays a tumor suppressive role in GC. Single-cell analysis showed that HNF4A was selectively expressed in gastric epithelial cells. Besides, the reduced HNF4A expression in GC was due to promoter DNA hypermethylation. More importantly, we have provided strong evidence that Hp. infection causes HNF4A down-regulation by hypermethylation of its gene promoter. Meanwhile, silencing of HNF4A resulted in loss of epithelial polarity and activation of TGFβ-induced EMT signaling in gastric epithelial cells by transcriptionally regulating the expression of downstream target genes. In addition, the rescue assays indicated that Hp. infection activated EMT signaling of gastric epithelial cells in a HNF4A-dependent manner, thereby driving gastric tumorigenesis and metastasis. In conclusion, HNF4A is a tumor suppressor gene in GC. Hp. infection causes silence of the HNF4A gene by hypermethylation of its promoter, which then disrupts epithelial polarity and induces EMT signaling in gastric epithelial cells, thereby driving gastric tumorigenesis and metastasis.
- 6 October 2025
- Published by Springer Nature in Cell Death & Disease
- Vol. 16 (1) , 1-15
Open AccessHypermethylation-mediated HNF4A silencing by Helicobacter pylori infection drives gastric cancer by disrupting epithelial cell polarity and activating EMT signaling
Helicobacter pylori (Hp.) infection is one of the high-risk factors for gastric carcinogenesis (GC). However, the underlying mechanism remains largely unclear. In this study, we uncover an essential role of Hp. infection in mediating tumor suppressor gene silencing in gastric epithelial cells through promoter DNA hypermethylation. Hepatocyte nuclear factor HNF4A was downregulated in GC and predicted poor survival. The in vitro and in vivo assays together confirmed that HNF4A plays a tumor suppressive role in GC. Single-cell analysis showed that HNF4A was selectively expressed in gastric epithelial cells. Besides, the reduced HNF4A expression in GC was due to promoter DNA hypermethylation. More importantly, we have provided strong evidence that Hp. infection causes HNF4A down-regulation by hypermethylation of its gene promoter. Meanwhile, silencing of HNF4A resulted in loss of epithelial polarity and activation of TGFβ-induced EMT signaling in gastric epithelial cells by transcriptionally regulating the expression of downstream target genes. In addition, the rescue assays indicated that Hp. infection activated EMT signaling of gastric epithelial cells in a HNF4A-dependent manner, thereby driving gastric tumorigenesis and metastasis. In conclusion, HNF4A is a tumor suppressor gene in GC. Hp. infection causes silence of the HNF4A gene by hypermethylation of its promoter, which then disrupts epithelial polarity and induces EMT signaling in gastric epithelial cells, thereby driving gastric tumorigenesis and metastasis.
- 18 November 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 283 (Pt 3) , 137565
Receptor accessory protein 6, a novel ferroptosis suppressor, drives oral squamous cell carcinoma by maintaining endoplasmic reticulum hemostasis
- 18 November 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 283 (Pt 3) , 137565
Receptor accessory protein 6, a novel ferroptosis suppressor, drives oral squamous cell carcinoma by maintaining endoplasmic reticulum hemostasis
- Open Access
- 16 August 2024
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 12, 1409487
The effects of antimicrobial peptides buCaTHL4B and Im-4 on infectious root canal biofilms
Purpose: The primary cause of pulp and periapical diseases is the invasion of bacteria into the root canal, which results from the continuous destruction of dental hard tissues. Effective management of infections during root canal therapy necessitates effectively irrigation. This study aims to investigate the effects of two antimicrobial peptides (AMPs), buCaTHL4B and Im-4, on root canal biofilms in vitro.Methods: Two-species biofilms (Enterococcus faecalis and Fusobacterium nucleatum) were selected and anaerobically cultivated. The following treatments were applied: 10 μg/mL buCaTHL4B, 10 μg/mL Im-4, 5 μg/mL buCaTHL4B, 5 μg/mL Im-4, 1 μg/mL buCaTHL4B, 1 μg/mL Im-4, 1% NaOCl, and sterile water. Each group was treated for 3 min. Subsequently, the two strains were co-cultured with 10 μg/mL buCaTHL4B, 10 μg/mL Im-4, 1% NaOCl, and sterile water for 24, 48, and 72 h. The biofilms were examined using confocal laser scanning microscopy (CLSM) with fluorescent staining, and the percentages of dead bacteria were calculated. Quantitative real-time PCR (qRT-PCR) was employed to assess the variations in bacterial proportions during biofilm formation.Results: Compared to 1% NaOCl, 10 μg/mL buCaTHL4B or Im-4 exhibited significantly greater bactericidal effects on the two-species biofilms (p < 0.05), leading to their selection for subsequent experiments. Over a 48-hour period, 10 μg/mL Im-4 demonstrated a stronger antibiofilm effect than buCaTHL4B (p < 0.05). Following a 24-hour biofilm formation period, the proportion of F. nucleatum decreased while the proportion of E. faecalis increased in the sterile water group. In the buCaTHL4B and 1% NaOCl groups, the proportion of F. nucleatum was lower than that of E. faecalis (p < 0.05), whereas in the Im-4 group, the proportion of F. nucleatum was higher than that of E. faecalis (p < 0.05). The proportions of bacteria in the two AMPs groups gradually stabilized after 24 h of treatment.Conclusion: buCaTHL4B and Im-4 exhibited remarkable antibacterial and anti-biofilm capabilities against pathogenic root canal biofilms in vitro, indicating their potential as promising additives to optimize the effectiveness of root canal treatment as alternative irrigants.
- 16 August 2024
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 12, 1409487
Open AccessThe effects of antimicrobial peptides buCaTHL4B and Im-4 on infectious root canal biofilms
Purpose: The primary cause of pulp and periapical diseases is the invasion of bacteria into the root canal, which results from the continuous destruction of dental hard tissues. Effective management of infections during root canal therapy necessitates effectively irrigation. This study aims to investigate the effects of two antimicrobial peptides (AMPs), buCaTHL4B and Im-4, on root canal biofilms in vitro.Methods: Two-species biofilms (Enterococcus faecalis and Fusobacterium nucleatum) were selected and anaerobically cultivated. The following treatments were applied: 10 μg/mL buCaTHL4B, 10 μg/mL Im-4, 5 μg/mL buCaTHL4B, 5 μg/mL Im-4, 1 μg/mL buCaTHL4B, 1 μg/mL Im-4, 1% NaOCl, and sterile water. Each group was treated for 3 min. Subsequently, the two strains were co-cultured with 10 μg/mL buCaTHL4B, 10 μg/mL Im-4, 1% NaOCl, and sterile water for 24, 48, and 72 h. The biofilms were examined using confocal laser scanning microscopy (CLSM) with fluorescent staining, and the percentages of dead bacteria were calculated. Quantitative real-time PCR (qRT-PCR) was employed to assess the variations in bacterial proportions during biofilm formation.Results: Compared to 1% NaOCl, 10 μg/mL buCaTHL4B or Im-4 exhibited significantly greater bactericidal effects on the two-species biofilms (p < 0.05), leading to their selection for subsequent experiments. Over a 48-hour period, 10 μg/mL Im-4 demonstrated a stronger antibiofilm effect than buCaTHL4B (p < 0.05). Following a 24-hour biofilm formation period, the proportion of F. nucleatum decreased while the proportion of E. faecalis increased in the sterile water group. In the buCaTHL4B and 1% NaOCl groups, the proportion of F. nucleatum was lower than that of E. faecalis (p < 0.05), whereas in the Im-4 group, the proportion of F. nucleatum was higher than that of E. faecalis (p < 0.05). The proportions of bacteria in the two AMPs groups gradually stabilized after 24 h of treatment.Conclusion: buCaTHL4B and Im-4 exhibited remarkable antibacterial and anti-biofilm capabilities against pathogenic root canal biofilms in vitro, indicating their potential as promising additives to optimize the effectiveness of root canal treatment as alternative irrigants.
- Open Access
- 5 July 2024
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 43 (1) , 1-17
lncRNA FGD5-AS1 is required for gastric cancer proliferation by inhibiting cell senescence and ROS production via stabilizing YBX1
Background: The vast majority of lncRNAs have low expression abundance, which greatly limits their functional range and impact. As a high expression abundance lncRNA, FGD5-AS1’s non-ceRNA biological function in cancer is unclear. Methods: RNA-seq studies and chromatin immunoprecipitation (Chip) assays were performed to identify ZEB1-regulated lncRNAs. RNA sequencing, RNA pulldown, RNA Immunoprecipitation assays, and rescue assays were conducted to explore the molecular mechanisms of FGD5-AS1 in GC. Results: As one of the most abundant lncRNAs in cells, FGD5-AS1 has been shown to be transcriptionally activated by ZEB1, thus closely related to epithelial-mesenchymal transition (EMT) signaling. Clinical analysis showed that FGD5-AS1 overexpression was clinically associated with lymph node metastasis, and predicted poor survival in GC. Loss-of-function studies confirmed that FGD5-AS1 knockdown inhibited GC proliferation and induced cisplatin chemosensibility, cell senescence, and DNA damage in GC cells. Mechanismically, FGD5-AS1 is a YBX1-binding lncRNA due to its mRNA contains three adjacent structural motifs (UAAUCCCA, ACCAGCCU, and CAGUGAGC) that can be recognized and bound by YBX1. And this RNA-protein interaction prolonged the half-life of the YBX1 protein in GC. Additionally, a rescue assay showed that FGD5-AS1 promotes GC by repressing cell senescence and ROS production via YBX1. Conclusion: FGD5-AS1 is a cellular high-abundant lncRNA that is transcriptionally regulated by ZEB1. FGD5-AS1 overexpression promoted GC progression by inhibiting cell senescence and ROS production through binding and stabilizing the YBX1 protein.
- 5 July 2024
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 43 (1) , 1-17
Open AccesslncRNA FGD5-AS1 is required for gastric cancer proliferation by inhibiting cell senescence and ROS production via stabilizing YBX1
Background: The vast majority of lncRNAs have low expression abundance, which greatly limits their functional range and impact. As a high expression abundance lncRNA, FGD5-AS1’s non-ceRNA biological function in cancer is unclear. Methods: RNA-seq studies and chromatin immunoprecipitation (Chip) assays were performed to identify ZEB1-regulated lncRNAs. RNA sequencing, RNA pulldown, RNA Immunoprecipitation assays, and rescue assays were conducted to explore the molecular mechanisms of FGD5-AS1 in GC. Results: As one of the most abundant lncRNAs in cells, FGD5-AS1 has been shown to be transcriptionally activated by ZEB1, thus closely related to epithelial-mesenchymal transition (EMT) signaling. Clinical analysis showed that FGD5-AS1 overexpression was clinically associated with lymph node metastasis, and predicted poor survival in GC. Loss-of-function studies confirmed that FGD5-AS1 knockdown inhibited GC proliferation and induced cisplatin chemosensibility, cell senescence, and DNA damage in GC cells. Mechanismically, FGD5-AS1 is a YBX1-binding lncRNA due to its mRNA contains three adjacent structural motifs (UAAUCCCA, ACCAGCCU, and CAGUGAGC) that can be recognized and bound by YBX1. And this RNA-protein interaction prolonged the half-life of the YBX1 protein in GC. Additionally, a rescue assay showed that FGD5-AS1 promotes GC by repressing cell senescence and ROS production via YBX1. Conclusion: FGD5-AS1 is a cellular high-abundant lncRNA that is transcriptionally regulated by ZEB1. FGD5-AS1 overexpression promoted GC progression by inhibiting cell senescence and ROS production through binding and stabilizing the YBX1 protein.
- Open Access
- 28 May 2024
- Published by Springer Nature in Cell Death & Disease
- Vol. 15 (5) , 1-14
A novel TGFbeta/TGILR axis mediates crosstalk between cancer-associated fibroblasts and tumor cells to drive gastric cancer progression
Transforming growth factor beta (TGFβ) signaling plays a critical role in tumorigenesis and metastasis. However, little is known about the biological function of TGFbeta-induced lncRNA in cancer. In this study, we discovered a novel TGFbeta-induced lncRNA, termed TGILR, whose function in cancer remains unknown to date. TGILR expression was directly activated by the canonical TGFbeta/SMAD3 signaling axis, and this activation is highly conserved in cancer. Clinical analysis showed that TGILR overexpression showed a significant correlation with lymph node metastasis and poor survival and was an independent prognostic factor in gastric cancer (GC). Depletion of TGILR caused an obvious inhibitory effect on GC cell proliferation, invasion, and epithelial-mesenchymal transition (EMT) in vitro and in vivo. More importantly, we demonstrated that TGFbeta signaling in GC was overactivated due to cancer-associated fibroblast (CAF) infiltration. Mechanistically, increased level of CAF-secreted TGFbeta activates TGFbeta signaling, leading to TGILR overexpression in GC cells. Meanwhile, TGILR overexpression inhibited the microRNA biogenesis of miR-1306 and miR-33a by interacting with TARBP2 and reducing its protein stability, thereby promoting GC progression via TCF4-mediated EMT signaling. In conclusion, CAF infiltration drives GC metastasis and EMT signaling through activating TGFbeta/TGILR axis. Targeted blocking of CAF-derived TGFbeta should be a promising anticancer strategy in GC.
- 28 May 2024
- Published by Springer Nature in Cell Death & Disease
- Vol. 15 (5) , 1-14
Open AccessA novel TGFbeta/TGILR axis mediates crosstalk between cancer-associated fibroblasts and tumor cells to drive gastric cancer progression
Transforming growth factor beta (TGFβ) signaling plays a critical role in tumorigenesis and metastasis. However, little is known about the biological function of TGFbeta-induced lncRNA in cancer. In this study, we discovered a novel TGFbeta-induced lncRNA, termed TGILR, whose function in cancer remains unknown to date. TGILR expression was directly activated by the canonical TGFbeta/SMAD3 signaling axis, and this activation is highly conserved in cancer. Clinical analysis showed that TGILR overexpression showed a significant correlation with lymph node metastasis and poor survival and was an independent prognostic factor in gastric cancer (GC). Depletion of TGILR caused an obvious inhibitory effect on GC cell proliferation, invasion, and epithelial-mesenchymal transition (EMT) in vitro and in vivo. More importantly, we demonstrated that TGFbeta signaling in GC was overactivated due to cancer-associated fibroblast (CAF) infiltration. Mechanistically, increased level of CAF-secreted TGFbeta activates TGFbeta signaling, leading to TGILR overexpression in GC cells. Meanwhile, TGILR overexpression inhibited the microRNA biogenesis of miR-1306 and miR-33a by interacting with TARBP2 and reducing its protein stability, thereby promoting GC progression via TCF4-mediated EMT signaling. In conclusion, CAF infiltration drives GC metastasis and EMT signaling through activating TGFbeta/TGILR axis. Targeted blocking of CAF-derived TGFbeta should be a promising anticancer strategy in GC.
- Open Access
- 10 May 2024
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 28 (6) , 1-15
Association between periodontitis and dental caries: a systematic review and meta-analysis
Objectives: Recent evidence suggested a link between periodontitis (PD) and dental caries, but the trends and nature of this association remained unclear. The overall aim of this study was to critically assess the correlation of two disorders. Methods: A comprehensive search was conducted within the PUBMED and EMBASE databases including grey literatures up to July 5th, 2023. The Newcastle–Ottawa scale was used to qualitatively evaluate the risk of bias. Results: Overall, 18 studies were included. In terms of caries risk in PD patients, the prevalence of caries was increased by PD (OR = 1.57, 95%CI:1.20–2.07), both in crown (OR = 1.03, 95%CI:1.01–1.05) and root caries (OR = 2.10, 95%CI:1.03–4.29). Odds of caries were also raised by PD severity (OR moderate = 1.38, 95%CI:1.15–1.66; OR severe = 2.14, 95%CI:1.74–2.64). Besides, patients with PD exhibited a higher mean number of decayed, missing and filled teeth (DMFT) and decayed and filled root teeth (DFR) [weighted mean difference (WMD)DMFT = 0.87, 95%CI: -0.03–1.76; WMDDFR = 1.13, 95%CI: 0.48–1.78]. Likewise, patients with caries had an elevated risk of PD (OR = 1.79, 95%CI:1.36–2.35). However, Streptococcus mutans, one of the main pathogens of caries, was negatively correlated with several main pathogens of periodontitis. Conclusions: This study indicated a positive correlation between dental caries and periodontitis clinically, while the two disease-associated pathogens were antagonistic. Clinical relevance: Further research, including clinical cohort studies and mechanisms of pathogens interaction is needed on this link for better prevention and treatment of PD and caries. In addition, innovative prevention strategies need to be developed and incorporated in dental practices to prevent these two highly prevalent oral diseases.
- 10 May 2024
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 28 (6) , 1-15
Open AccessAssociation between periodontitis and dental caries: a systematic review and meta-analysis
Objectives: Recent evidence suggested a link between periodontitis (PD) and dental caries, but the trends and nature of this association remained unclear. The overall aim of this study was to critically assess the correlation of two disorders. Methods: A comprehensive search was conducted within the PUBMED and EMBASE databases including grey literatures up to July 5th, 2023. The Newcastle–Ottawa scale was used to qualitatively evaluate the risk of bias. Results: Overall, 18 studies were included. In terms of caries risk in PD patients, the prevalence of caries was increased by PD (OR = 1.57, 95%CI:1.20–2.07), both in crown (OR = 1.03, 95%CI:1.01–1.05) and root caries (OR = 2.10, 95%CI:1.03–4.29). Odds of caries were also raised by PD severity (OR moderate = 1.38, 95%CI:1.15–1.66; OR severe = 2.14, 95%CI:1.74–2.64). Besides, patients with PD exhibited a higher mean number of decayed, missing and filled teeth (DMFT) and decayed and filled root teeth (DFR) [weighted mean difference (WMD)DMFT = 0.87, 95%CI: -0.03–1.76; WMDDFR = 1.13, 95%CI: 0.48–1.78]. Likewise, patients with caries had an elevated risk of PD (OR = 1.79, 95%CI:1.36–2.35). However, Streptococcus mutans, one of the main pathogens of caries, was negatively correlated with several main pathogens of periodontitis. Conclusions: This study indicated a positive correlation between dental caries and periodontitis clinically, while the two disease-associated pathogens were antagonistic. Clinical relevance: Further research, including clinical cohort studies and mechanisms of pathogens interaction is needed on this link for better prevention and treatment of PD and caries. In addition, innovative prevention strategies need to be developed and incorporated in dental practices to prevent these two highly prevalent oral diseases.
- 12 March 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 131, 111836
Cancer-associated fibroblasts promote gastric cancer cell proliferation by paracrine FGF2-driven ribosome biogenesis
- 12 March 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 131, 111836
Cancer-associated fibroblasts promote gastric cancer cell proliferation by paracrine FGF2-driven ribosome biogenesis